Investor Relations

Investor Relations

Latest News View All News

Dec 5, 2019 • 8:45 AM EST

Cerecor to Acquire Aevi Genomic Medicine

Nov 14, 2019 • 6:30 AM EST

Cerecor Reports Third Quarter 2019 Results

Nov 11, 2019 • 6:30 AM EST

Cerecor Announces Clinical Updates on CERC-301 and CERC-802

Stock Information View Detailed Stock Information

Nasdaq: CERC Cerecor, Inc.
Price
Change
Volume
Day Range
52 Week Range

Company Overview

Cerecor is an integrated biopharmaceutical company developing innovative therapies at the cutting edge of science. Our pipeline, filled with forward-thinking ideas, propels us forward. We are driven to change the lives of patients with rare orphan diseases in Pediatrics and Neurology.